Similar articles

• [The pathogenesis and treatment of the hemostatic disorder in acute promyelocytic leukemia].

  Velasco F, López-Pedrera R, Páramo JA. Velasco F, et al. Med Clin (Barc). 1996 Jun 8;107(2):59-61. Med Clin (Barc). 1996. PMID: 8753897 Review. Spanish. No abstract available.
• [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].

  Degos L. Degos L. Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):193-5. Nouv Rev Fr Hematol (1978). 1993. PMID: 8337123 French.
• Management of acute promyelocytic leukemia.

  Fenaux P. Fenaux P. Eur J Haematol. 1993 Feb;50(2):65-73. doi: 10.1111/j.1600-0609.1993.tb00144.x. Eur J Haematol. 1993. PMID: 8382622 Review. No abstract available.
• Acute promyelocytic leukaemia in the all trans retinoic acid era.

  DeLoughery TG, Goodnight SH. DeLoughery TG, et al. Med Oncol. 1996 Dec;13(4):233-40. doi: 10.1007/BF02990936. Med Oncol. 1996. PMID: 9152974 Review.
• What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?

  Mantha S, Tallman MS, Soff GA. Mantha S, et al. Curr Opin Hematol. 2016 Mar;23(2):121-6. doi: 10.1097/MOH.0000000000000221. Curr Opin Hematol. 2016. PMID: 26760586 Review.